Latest update

SMC publishes an updated Collaborative Advice Document for COVID-19 medicines; update to the recommendations for nirmatrelvir plus ritonavir (update to TA878)

SMC publishes a Collaborative Advice Document for molnupiravir for COVID-19

April 2025 decisions news release

SMC advice on seven new medicines

NICE issues final draft guidance for use of molnupiravir for treatment of COVID-19

March 2025 decisions news release

SMC advice on four new medicines

February 2025 decisions news release

SMC advice on seven new medicines

Launch of Refreshed Innovative Licensing and Access Pathway (ILAP)

UK patients enabled access to transformative new medicines in shortest time possible via new, integrated Innovative Licensing and Access Pathway

Patient and Public Involvement End of Year Highlights Report 2024

View the flash report

January 2025 decisions news release

SMC advice on nine new medicines

December 2024 decisions news release

SMC advice on four new medicines